cedrene and Disease-Models--Animal

cedrene has been researched along with Disease-Models--Animal* in 2 studies

Other Studies

2 other study(ies) available for cedrene and Disease-Models--Animal

ArticleYear
α-Cedrene protects rodents from high-fat diet-induced adiposity via adenylyl cyclase 3.
    International journal of obesity (2005), 2019, Volume: 43, Issue:1

    The increasing global prevalence of obesity and its associated disorders points to an urgent need for the development of novel and effective strategies for the prevention of weight gain. Here, we investigated the potential of α-cedrene, a volatile sesquiterpene compound derived from cedarwood oil, in regulation of obesity and delineated the mechanisms involved.. For the prevention of obesity, C57BL/6 N mice were fed a high-fat diet (HFD) and were orally administered either with vehicle or α-cedrene for 8 weeks. For the therapy of obesity, obese Sprague Dawley rats, induced by a HFD for 8 weeks, were orally treated either with vehicle or α-cedrene for 12 weeks. To determine whether the action of α-cedrene was Adcy3 dependent, Adcy3 heterozygous null mice (Adcy3. Oral α-cedrene administration prevented or reversed HFD-induced obesity and abnormal metabolic aberrations in rodents, without affecting their food intake. Downregulation of Adcy3 expression by small interfering RNA abrogated the beneficial effects of α-cedrene on the oxygen consumption rate and intracellular lipid accumulation in 3T3-L1 adipocytes. Similarly, in Adcy3. Our results highlight the potential of α-cedrene for antiobesity interventions and suggest that the antiobesity effect of α-cedrene is mediated by Adcy3 in adipose tissues.

    Topics: 3T3-L1 Cells; Adenylyl Cyclases; Adiposity; Animals; Anti-Obesity Agents; Diet, High-Fat; Disease Models, Animal; Mice; Mice, Inbred C57BL; Polycyclic Sesquiterpenes; Rats; Rats, Sprague-Dawley

2019
Olfactory receptor 10J5 responding to α-cedrene regulates hepatic steatosis via the cAMP-PKA pathway.
    Scientific reports, 2017, 08-25, Volume: 7, Issue:1

    Ectopic expression and functions of odorant receptors (ORs) in the human body have aroused much interest in the past decade. Mouse olfactory receptor 23 (MOR23, olfr16) and its human orthologue, OR10J5, have been found to be functionally expressed in several non-olfactory systems. Here, using MOR23- and OR10J5-expressing Hana3A cells, we identified α-cedrene, a natural compound that protects against hepatic steatosis in mice fed the high-fat diet, as a novel agonist of these receptors. In human hepatocytes, an RNA interference-mediated knockdown of OR10J5 increased intracellular lipid accumulation, along with upregulation of lipogenic genes and downregulation of genes related to fatty acid oxidation. α-Cedrene stimulation resulted in a significant reduction in lipid contents of human hepatocytes and reprogramming of metabolic signatures, which are mediated by OR10J5, as demonstrated by receptor knockdown experiments using RNA interference. Taken together, our findings show a crucial role of OR10J5 in the regulation of lipid accumulation in human hepatocytes.

    Topics: Animals; Biomarkers; Calcium; Cyclic AMP; Diet, High-Fat; Disease Models, Animal; Gene Expression; Hep G2 Cells; Humans; Mice; Non-alcoholic Fatty Liver Disease; Olfactory Receptor Neurons; Polycyclic Sesquiterpenes; Receptors, Odorant; Sesquiterpenes; Signal Transduction; Triglycerides

2017